127 related articles for article (PubMed ID: 9797773)
1. Structural alterations of chromosome 5 in twelve human prostate cancer cell lines.
Ozen M; Navone NM; Multani AS; Troncoso P; Logothetis CJ; Chung LW; von Eschenbach AC; Pathak S
Cancer Genet Cytogenet; 1998 Oct; 106(2):105-9. PubMed ID: 9797773
[TBL] [Abstract][Full Text] [Related]
2. Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype.
Hukku B; Mally M; Cher ML; Peehl DM; Kung H; Rhim JS
Cancer Genet Cytogenet; 2000 Jul; 120(2):117-26. PubMed ID: 10942801
[TBL] [Abstract][Full Text] [Related]
3. Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate.
Lundgren R; Kristoffersson U; Heim S; Mandahl N; Mitelman F
Cancer Genet Cytogenet; 1988 Oct; 35(1):103-8. PubMed ID: 3180000
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis.
Sanjmyatav J; Schubert J; Junker K
Oncol Rep; 2005 Nov; 14(5):1183-7. PubMed ID: 16211283
[TBL] [Abstract][Full Text] [Related]
5. Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma.
Okamoto I; Pirker C; Bilban M; Berger W; Losert D; Marosi C; Haas OA; Wolff K; Pehamberger H
Neoplasia; 2005 Apr; 7(4):303-11. PubMed ID: 15967107
[TBL] [Abstract][Full Text] [Related]
6. Molecular cytogenetic characterization of eight small supernumerary marker chromosomes originating from chromosomes 2, 4, 8, 18, and 21 in three patients.
Pietrzak J; Mrasek K; Obersztyn E; Stankiewicz P; Kosyakova N; Weise A; Cheung SW; Cai WW; von Eggeling F; Mazurczak T; Bocian E; Liehr T
J Appl Genet; 2007; 48(2):167-75. PubMed ID: 17495351
[TBL] [Abstract][Full Text] [Related]
7. Consistent chromosomal losses in head and neck squamous cell carcinoma cell lines.
Sreekantaiah C; Rao PH; Xu L; Sacks PG; Schantz SP; Chaganti RS
Genes Chromosomes Cancer; 1994 Sep; 11(1):29-39. PubMed ID: 7529044
[TBL] [Abstract][Full Text] [Related]
8. [The application of fluorescence in situ hybridization performed on the decolorized G-banding chromosomes in detecting the marker chromosomes of gastric cancer].
Xia J; Zhang J; Guan X; Wang H; Liu Q; Zhang G; Li P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):274-7. PubMed ID: 10932014
[TBL] [Abstract][Full Text] [Related]
9. IGH gene involvement in two cases of acute lymphoblastic leukemia with t(14;14)(q11;q32) identified by sequential R-banding and fluorescence in situ hybridization.
Liu S; Bo L; Liu X; Li C; Qin S; Wang J
Cancer Genet Cytogenet; 2004 Jul; 152(2):141-5. PubMed ID: 15262434
[TBL] [Abstract][Full Text] [Related]
10. Specific cytogenetic aberrations in two novel human prostatic cell lines immortalized by human papillomavirus type 18 DNA.
Weijerman PC; van Drunen E; König JJ; Teubel W; Romijn JC; Schröder FH; Hagemeijer A
Cancer Genet Cytogenet; 1997 Dec; 99(2):108-15. PubMed ID: 9398864
[TBL] [Abstract][Full Text] [Related]
11. Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization.
Fu W; Bubendorf L; Willi N; Moch H; Mihatsch MJ; Sauter G; Gasser TC
Urology; 2000 Nov; 56(5):880-5. PubMed ID: 11068328
[TBL] [Abstract][Full Text] [Related]
12. Isochromosome 8q formation is associated with 8p loss of heterozygosity in a prostate cancer cell line.
Virgin JB; Hurley PM; Nahhas FA; Bebchuk KG; Mohamed AN; Sakr WA; Bright RK; Cher ML
Prostate; 1999 Sep; 41(1):49-57. PubMed ID: 10440875
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude mice.
Lensch R; Götz C; Andres C; Bex A; Lehmann J; Zwergel T; Unteregger G; Kamradt J; Stoeckle M; Wullich B
Int J Oncol; 2002 Oct; 21(4):695-706. PubMed ID: 12239607
[TBL] [Abstract][Full Text] [Related]
14. [Report on 16 rare species of human chromosomal].
Han WT; Wang G; Jiang M; Zhang ZF; Liu GX; Wang CX; Bian CY; Yu P
Yi Chuan; 2005 Mar; 27(2):201-4. PubMed ID: 15843345
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic studies in prostate cancer: are we making progress?
Brothman AR
Cancer Genet Cytogenet; 1997 May; 95(1):116-21. PubMed ID: 9140461
[TBL] [Abstract][Full Text] [Related]
16. Specific subtelomere loss on chromosome der(11)t(3;11)(q23;q23)x2 in anaplastic thyroid cancer cell line OCUT-1.
Kammori M; Onoda N; Nakamura K; Izumiyama N; Ogisawa K; Kurabayashi R; Ogawa T; Kaminishi M; Poon SS; Takubo K
Int J Mol Med; 2006 Jul; 18(1):9-16. PubMed ID: 16786150
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the malignant phenotype and genotype of the human androgen-independent cell line DU 145 and a subline derived from metastasis after orthotopic implantation in nude mice.
Bex A; Wullich B; Endris V; Otto T; Rembrink K; Stöckle M; Rübben H
Cancer Genet Cytogenet; 2001 Jan; 124(2):98-104. PubMed ID: 11172899
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts.
Williams BJ; Jones E; Kozlowski JM; Vessella R; Brothman AR
Genes Chromosomes Cancer; 1997 Apr; 18(4):299-304. PubMed ID: 9087570
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15.
Jackson-Cook C; Bae V; Edelman W; Brothman A; Ware J
Cancer Genet Cytogenet; 1996 Mar; 87(1):14-23. PubMed ID: 8646734
[TBL] [Abstract][Full Text] [Related]
20. Allelic loss of chromosomes 16q and 10q in human prostate cancer.
Carter BS; Ewing CM; Ward WS; Treiger BF; Aalders TW; Schalken JA; Epstein JI; Isaacs WB
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8751-5. PubMed ID: 1978938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
